Novelion Therapeutics, Inc. engages in the development and commercialization of pharmaceuitical products. It focuses in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is Market Cap of Novelion Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Novelion Therapeutics Inc market cap is N/A.
What is the 52-week high for Novelion Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Novelion Therapeutics Inc 52 week high is N/A as of September 12, 2025.
What is the 52-week low for Novelion Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Novelion Therapeutics Inc 52 week low is N/A as of September 12, 2025.
What was Novelion Therapeutics Inc stock price yesterday?
Novelion Therapeutics Inc stock price yesterday was $0.702.
What is the PE ratio of Novelion Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Novelion Therapeutics Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Novelion Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Novelion Therapeutics Inc P/B ratio is None.
What is Novelion Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Novelion Therapeutics Inc's EBITDA is -20.91.
What is the 50-day moving average of Novelion Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Novelion Therapeutics Inc 50-day moving average is N/A.
How many employess does Novelion Therapeutics Inc has?